氟氧头孢对呼吸道感染疗效的临床观察
Observation on clinical effects of flomoxef in treatment of infections of respiratory tract
-
摘要: 本文对比了氟氧头孢(flomoxef,FMX)与对照药头孢美唑(cefmetazone,CMZ)对呼吸道感染患者的临床疗效和不良反应,尽管随机分组中FMX组患者年龄偏大,基础疾病相对较多,但FMX组痊愈率为63.6%,有效率为90.9%,与CMZ组无显着差异;尤其FMX对金黄色葡萄球菌感染最有效(100%痊愈),细菌清除率(100%)亦比CMZ组(88.9%)高,未见任何不良反应,从而提示FMX为一安全有效的新抗生素。
-
关键词:
- 氟氧头孢(flomoxef) /
- 临床疗效 /
- 不良反应
Abstract: The clinical response and adverse reaction of flomoxef (FMX) in treatment of the patients with respiratory infections were compared with controlled drug-cefmetazone(CMZ) in the study. The results showed that although the age of the patients in group FMZ was older and the serious underground diseases were more than group CMX, but in group FMX, the cured rate was 63.6%, the effective rate was 90.9%, there was no significant difference between the two groups. Especially FMX was the best drug to treat the infections caused by S. aureus(cured rate was 100%). The rate of bacteria clearance of FMX was higher(100%) than CMZ(88.9%), there was no adverse reaction in the group.It is suggested that FMX was a safe and effective antibiotic.-
Key words:
- flomoxef /
- clinical respone /
- adverse reaction
计量
- 文章访问数: 2436
- HTML全文浏览量: 291
- PDF下载量: 310
- 被引次数: 0